Skip to main content
. 2022 Jan 22;9(8):2104472. doi: 10.1002/advs.202104472

Figure 5.

Figure 5

In vitro anticancer activity of JX06‐NPs combined with Met on PDC cells from patientEC+/dia+ diagnosed with stage IA grade 2 (IAG2) EC. A) Flowcharts of PDC for the drug‐sensitivity test. B) Tumor specimen was collected from patientEC+/dia+ diagnosed with stage IA grade 2 (IAG2) EC, and immuno‐histochemistry staining showed ER (60%++), Ki67 (40%+), PR (80%+++), and phosphatase and tensin homolog (PTEN) (−). C) Viability of PDC cells after treatment with JX06, JX06‐NPs, and Met. Data are shown as mean ± SD. One‐way ANOVA. **P < 0.01.